ATE518867T1 - Benzothienoä2,3-düpyrimidin-verindungen als inhibitoren der aktivität der tyrosinkinase epidermaler wachstumsfaktorrezeptoren zur behandlung hyperproliferativer krankheiten - Google Patents
Benzothienoä2,3-düpyrimidin-verindungen als inhibitoren der aktivität der tyrosinkinase epidermaler wachstumsfaktorrezeptoren zur behandlung hyperproliferativer krankheitenInfo
- Publication number
- ATE518867T1 ATE518867T1 AT05815411T AT05815411T ATE518867T1 AT E518867 T1 ATE518867 T1 AT E518867T1 AT 05815411 T AT05815411 T AT 05815411T AT 05815411 T AT05815411 T AT 05815411T AT E518867 T1 ATE518867 T1 AT E518867T1
- Authority
- AT
- Austria
- Prior art keywords
- düpyrimidine
- tyrosinkinase
- inhibitors
- activity
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61906604P | 2004-10-15 | 2004-10-15 | |
| PCT/US2005/036791 WO2006044524A1 (en) | 2004-10-15 | 2005-10-14 | Benzothieno’2,3-d! pyrimidine compounds as inhibitors of tyrosine kinase activities of the epidermal growth factor receptors (egfrs) for the treatment of hyperproliferative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE518867T1 true ATE518867T1 (de) | 2011-08-15 |
Family
ID=35759133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05815411T ATE518867T1 (de) | 2004-10-15 | 2005-10-14 | Benzothienoä2,3-düpyrimidin-verindungen als inhibitoren der aktivität der tyrosinkinase epidermaler wachstumsfaktorrezeptoren zur behandlung hyperproliferativer krankheiten |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7750017B2 (de) |
| EP (1) | EP1802633B1 (de) |
| JP (1) | JP5070058B2 (de) |
| AR (1) | AR052019A1 (de) |
| AT (1) | ATE518867T1 (de) |
| CA (1) | CA2584303A1 (de) |
| ES (1) | ES2369235T3 (de) |
| GT (1) | GT200500291A (de) |
| PE (1) | PE20060976A1 (de) |
| TW (1) | TW200628473A (de) |
| UY (1) | UY29161A1 (de) |
| WO (1) | WO2006044524A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7960400B2 (en) | 2007-08-27 | 2011-06-14 | Duquesne University Of The Holy Ghost | Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| US7982035B2 (en) | 2007-08-27 | 2011-07-19 | Duquesne University Of The Holy Spirit | Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| WO2009104026A1 (en) * | 2008-02-19 | 2009-08-27 | Vichem Chemie Kutató Kft | Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use |
| SI2317852T1 (sl) | 2008-07-16 | 2015-04-30 | Richter Gedeon Nyrt. | Farmacevtske formulacije, ki vsebujejo ligande dopaminskega receptorja |
| WO2014011902A1 (en) * | 2012-07-11 | 2014-01-16 | Nimbus Iris, Inc. | Irak inhibitors and uses thereof |
| CN105189518A (zh) * | 2013-02-01 | 2015-12-23 | 拜耳制药股份公司 | 取代的噻吩并吡啶和其药物用途 |
| TW201605867A (zh) * | 2013-11-20 | 2016-02-16 | 拜耳製藥公司 | 噻吩并嘧啶 |
| HU231173B1 (hu) | 2016-07-08 | 2021-06-28 | Richter Gedeon Nyrt. | Ipari eljárás cariprazine előállítására |
| US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
| TWI813611B (zh) | 2017-12-21 | 2023-09-01 | 美商律幫治療股份有限公司 | 作為parp14抑制劑之喹唑啉酮 |
| CN108285421A (zh) * | 2018-01-26 | 2018-07-17 | 黑龙江鑫创生物科技开发有限公司 | 一种微通道反应器合成拉帕替尼中间体的方法 |
| CN108456184B (zh) * | 2018-03-28 | 2020-02-07 | 南方医科大学 | 一种靶向egfr与eps8结合的小分子抑制剂及其应用 |
| US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
| CN110818618A (zh) * | 2019-11-26 | 2020-02-21 | 山东铂源药业有限公司 | 一种吡咯替尼中间体2-[(2-氯-4-硝基苯氧基)甲基]吡啶的合成方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5679683A (en) * | 1994-01-25 | 1997-10-21 | Warner-Lambert Company | Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| GB9520822D0 (en) | 1995-10-11 | 1995-12-13 | Wellcome Found | Therapeutically active compounds |
| NZ332119A (en) * | 1996-04-12 | 2001-08-31 | Warner Lambert Co | Quinazoline compounds which are irreversible inhibitors of tyrosine kinases |
-
2005
- 2005-10-13 AR ARP050104298A patent/AR052019A1/es not_active Application Discontinuation
- 2005-10-13 UY UY29161A patent/UY29161A1/es not_active Application Discontinuation
- 2005-10-14 PE PE2005001212A patent/PE20060976A1/es not_active Application Discontinuation
- 2005-10-14 US US11/665,313 patent/US7750017B2/en not_active Expired - Fee Related
- 2005-10-14 CA CA002584303A patent/CA2584303A1/en not_active Abandoned
- 2005-10-14 WO PCT/US2005/036791 patent/WO2006044524A1/en active Application Filing
- 2005-10-14 ES ES05815411T patent/ES2369235T3/es active Active
- 2005-10-14 GT GT200500291A patent/GT200500291A/es unknown
- 2005-10-14 TW TW094135793A patent/TW200628473A/zh unknown
- 2005-10-14 JP JP2007536874A patent/JP5070058B2/ja not_active Expired - Fee Related
- 2005-10-14 AT AT05815411T patent/ATE518867T1/de not_active IP Right Cessation
- 2005-10-14 EP EP05815411A patent/EP1802633B1/de not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| ES2369235T3 (es) | 2011-11-28 |
| US20080132497A1 (en) | 2008-06-05 |
| TW200628473A (en) | 2006-08-16 |
| WO2006044524A1 (en) | 2006-04-27 |
| GT200500291A (es) | 2006-10-10 |
| PE20060976A1 (es) | 2006-10-20 |
| JP2008516963A (ja) | 2008-05-22 |
| JP5070058B2 (ja) | 2012-11-07 |
| UY29161A1 (es) | 2006-04-28 |
| CA2584303A1 (en) | 2006-04-27 |
| US7750017B2 (en) | 2010-07-06 |
| AR052019A1 (es) | 2007-02-28 |
| EP1802633B1 (de) | 2011-08-03 |
| EP1802633A1 (de) | 2007-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE518867T1 (de) | Benzothienoä2,3-düpyrimidin-verindungen als inhibitoren der aktivität der tyrosinkinase epidermaler wachstumsfaktorrezeptoren zur behandlung hyperproliferativer krankheiten | |
| DE602005007717D1 (de) | Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen | |
| DE602005017503D1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
| DE602005005810D1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| DE602005026984D1 (de) | Chinolin-derivate zur behandlung von latenter tuberkulose | |
| ATE476414T1 (de) | Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen | |
| ATE369333T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| ATE375977T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| EP1804794A4 (de) | Spiropiperidin-verbindungen als beta-secretase-hemmer zur behandlung der alzheimer-krankheit | |
| ATE542823T1 (de) | 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen | |
| ATE512663T1 (de) | Kombination zur behandlung von erkrankungen mit zellproliferation | |
| DE602006019560D1 (de) | 2-cyanobenzolsulfonamidverbindungen zur behandlung von samen | |
| NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
| ATE517085T1 (de) | Zur behandlung von atemwegserkrankungen geeignete phenoxyessigsäurederivate | |
| ATE527241T1 (de) | Pyridiazinonderivate zur behandlung von tumoren | |
| DE602005012481D1 (de) | 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck | |
| ATE534633T1 (de) | Indazolderivate zur behandlung von hsp90- induzierten krankheiten | |
| DE602007011906D1 (de) | Tetrahydropyridothienpyrimidin-verbindungen und verwendung zur behandlung proliferativer erkrankungen | |
| DE602005027388D1 (de) | Malonsäureamidderivate als inhibitoren von g-sekretase zur behandlung von alzheimer-krankheit | |
| ATE439347T1 (de) | 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia | |
| ATE443991T1 (de) | Verwendung von phenylsemicarbazonen für die saatgutbeizung | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| ATE526970T1 (de) | Behandlung von mastitis | |
| DE602006021192D1 (de) | Visnadin zur Behandlung von Kopfhautjucken |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |